Recce Pharmaceuticals Ltd (ASX:RCE)
Australia · Delayed Price · Currency is AUD 0.4820
-0.0180 (-3.60%)
May 11, 2026, 11:30 AM AEST
Recce Pharmaceuticals Market Cap
Recce Pharmaceuticals has a market cap or net worth of 144.59 million as of May 8, 2026. Its market cap has increased by 99.65% in one year.
Market Cap
144.59M
Enterprise Value
145.03M
Revenue
974.56K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.48
Market Cap Chart
Since January 15, 2016, Recce Pharmaceuticals's market cap has increased from 20.55M to 144.59M, an increase of 603.70%. That is a compound annual growth rate of 20.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 144.59M | -23.08% |
| Dec 31, 2025 | 187.97M | 67.15% |
| Dec 31, 2024 | 112.46M | 3.19% |
| Dec 29, 2023 | 108.98M | -7.28% |
| Dec 30, 2022 | 117.53M | -34.34% |
| Dec 31, 2021 | 179.00M | -2.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tetratherix | 252.81M |
| Orthocell | 233.32M |
| Actinogen Medical | 168.80M |
| Nyrada | 137.17M |
| Dimerix | 129.09M |
| Alterity Therapeutics | 119.63M |
| Island Pharmaceuticals | 104.31M |
| Paradigm Biopharmaceuticals | 97.21M |